You are here

Clinical Trials: Spinal Cord Injuries

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, August 1, 2023 - 12:00
Condition:   Safety Issues
Intervention:   Procedure: Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels
Sponsor:   Kunming Tongren Hospital
Posted: Friday, January 20, 2023 - 12:00
Condition:   Spinal Cord Injury, Acute
Interventions:   Biological: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells;   Other: Control vehicle (sterile saline)
Sponsors:   Sklifosovsky Institute of Emergency Care;   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   K.L. Hetagurov North-Osetian State University
Posted: Friday, September 23, 2022 - 12:00
Conditions:   Spinal Cord Injuries;   Tetraplegia
Intervention:   Device: Testing of MyHand-SCI Device
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Posted: Thursday, December 9, 2021 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Posted: Thursday, September 23, 2021 - 12:00
Condition:   Spinal Cord Injury Cervical
Interventions:   Drug: WJ-MSC (XCEL-UMC-BETA);   Drug: Placebo
Sponsors:   Banc de Sang i Teixits;   Institut Guttmann;   Academic Research Organization (ARO) - VHIR
Not yet recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: autologous adipose derived mesenchymal stem cells
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Posted: Tuesday, March 23, 2021 - 12:00
Conditions:   Spinal Cord Injury, Acute;   Spinal Cord Injury at C4 Level With Complete Lesion;   Spinal Cord Injury at C5-C7 Level With Complete Lesion
Intervention:   Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors:   S.Biomedics Co., Ltd.;   Linical Co., Ltd.;   Yonsei University
Not yet recruiting
Posted: Thursday, August 27, 2020 - 12:00
Condition:   Spinal Cord Injury
Interventions:   Biological: Autologous bone marrow-derived mononuclear cells;   Drug: Placebo
Sponsor:   Shanghai Changzheng Hospital
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Conditions:   Spinal Cord Injuries;   Paralysis
Interventions:   Other: Best Medical Management: Occupational and Physical Therapy;   Biological: Autologous, Adipose Derived Mesenchymal Stem Cells
Sponsor:   Allan Dietz
Posted: Friday, February 28, 2020 - 12:00
Condition:   Spinal Cord Injuries
Interventions:   Biological: Collection and expansion of BM-MSC;   Diagnostic Test: VI-SCI evaluation and patients' follow up
Sponsor:   University of Jordan